C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/715 (2006.01) A61K 38/19 (2006.01) A61P 19/02 (2006.01) A61P 37/02 (2006.01) C07K 19/00 (2006.01) C12N 15/12 (2006.01) C12N 15/62 (2006.01)
Patent
CA 2710040
A soluble tumor necrosis factor receptor 2 (TNFRII) mutant has an amino acid substitution at position 92Glu compared with the wild TNFRII. The mutant improves the cytotoxicity capacity of neutralizing TNFalpha and lymphotoxin. The mutant and fusion protein comprising it are useful for the treatment of TNFalpha and lymphotoxin related diseases.
Un récepteur 2 de facteur de nécrose tumorale (TNFR2) mutant et soluble présente une substitution d'acide aminé à la position 92 Glu par rapport au TNFRII de type sauvage. La mutation augmente l'effet cytotoxique des TNF-alpha et TNF-beta. La mutation et la protéine de fusion en découlant peuvent être utilisées dans le traitement des maladies liées aux TNF-alpha et TNF-beta.
Liu Yanjun
Shen Yijun
Wu Fang
Wu Jinsong
Yang Tong
Kirby Eades Gale Baker
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.
Taizhou Fudan-Zhangjiang Pharmaceutical Co. Ltd.
LandOfFree
A soluble tumor necrosis factor receptor mutant does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A soluble tumor necrosis factor receptor mutant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A soluble tumor necrosis factor receptor mutant will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1987818